Al-Walid A. Mohsen,Gerard Vockley,Yudong Wang,Peter Wipf
申请号：
US16098322
公开号：
US20190142893A1
申请日:
2017.05.05
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A method is provided for treating a fatty acid oxidation metabolic condition, such as an inborn error of fatty acid oxidation or oxidative phosphorylation, and/or hypoglycemia, rhabdomyolysis, or cardiomyopathy in a patient. A mitochondrial-targeted electron, radical, or ROS-scavenging agent is administered to the patient in an amount effective to treat, mitigate or prevent any fatty acid oxidation metabolic condition, such as inborn errors of fatty acid oxidation or oxidative phosphorylation, and/or hypoglycemia, rhabdomyolysis, or cardiomyopathy in a patient.
